Detalhe da pesquisa
1.
Identification of TCR rearrangements specific for genetic alterations in EGFR-mutated non-small cell lung cancer: results from the ADJUVANT-CTONG1104 trial.
Cancer Immunol Immunother;
72(5): 1261-1272, 2023 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36427086
2.
Wait-and-See Treatment Strategy Could be Considered for Lung Adenocarcinoma with Special Pleural Dissemination Lesions, and Low Genomic Instability Correlates with Better Survival.
Ann Surg Oncol;
27(10): 3808-3818, 2020 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32239339
3.
Toward an Expert Level of Lung Cancer Detection and Classification Using a Deep Convolutional Neural Network.
Oncologist;
24(9): 1159-1165, 2019 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30996009
4.
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study.
Lancet Oncol;
19(1): 139-148, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29174310
5.
Characterization of PD-L1 expression in Chinese non-small cell lung cancer patients with PTEN expression as a means for tissue quality screening.
Cancer Immunol Immunother;
67(3): 471-481, 2018 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29214427
6.
Supraclavicular lymph node incisional biopsies have no influence on the prognosis of advanced non-small cell lung cancer patients: a retrospective study.
World J Surg Oncol;
15(1): 12, 2017 Jan 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28069039
7.
A lobe-specific lymphadenectomy protocol for solitary pulmonary nodules in non-small cell lung cancer.
Chin J Cancer Res;
27(6): 538-44, 2015 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26752927
8.
Single nucleotide polymorphisms of MAGE-A3 gene and its clinical implications in Chinese patients with non-small cell lung cancer (NSCLC).
Chin J Cancer Res;
27(3): 301-8, 2015 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26157327
9.
Lung cancer treatment disparities in China: a question in need of an answer.
Oncologist;
19(10): 1084-90, 2014 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25223463
10.
Comparison of three mathematical prediction models in patients with a solitary pulmonary nodule.
Chin J Cancer Res;
26(6): 647-52, 2014 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25561761
11.
CtDNA based molecular residual disease outcompetes carcinoembryonic antigen in predicting postoperative recurrence of non-small cell lung cancer.
J Thorac Dis;
16(1): 423-429, 2024 Jan 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38410594
12.
Impact of preoperative [18F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study.
Ann Nucl Med;
38(3): 188-198, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38145431
13.
Adjuvant Therapy-Free Strategy for Stage IB to IIIA Non-Small-Cell Lung Cancer Patients After Radical Resection Based on Longitudinal Undetectable Molecular Residual Disease: Prospective, Multicenter, Single-Arm Study (CTONG 2201).
Clin Lung Cancer;
25(1): e1-e4, 2024 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37880076
14.
BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification.
Mol Cancer;
12: 61, 2013 Jun 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23758992
15.
Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies.
J Transl Med;
11: 168, 2013 Jul 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23842453
16.
Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study.
Signal Transduct Target Ther;
8(1): 442, 2023 12 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38057314
17.
Lack of incremental value of three-dimensional measurement in assessing invasiveness for lung cancer.
Eur J Cardiothorac Surg;
64(6)2023 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37975876
18.
Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial.
Signal Transduct Target Ther;
8(1): 76, 2023 02 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36823150
19.
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients.
Cancer Cell;
41(10): 1763-1773.e4, 2023 10 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37816331
20.
EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomas.
Oncologist;
17(7): 978-85, 2012.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22673630